🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: \- to evaluate the efficacy of Sarilumab in participant...
Status
Completed
Location
Investigational Site Number 840006
Start Date
2010-02
Trial ID
NCT01061723
Background: Mast cells help the body fight disease and heal wounds. People...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2019-06-19
Trial ID
NCT03770273
This is a randomized, double-blind, placebo-controlled, parallel-group, Pha...
Status
Recruiting
Location
Denver Arthritis Clinic - Lowry- Site Number : 8400001
Start Date
2026-05-12
Trial ID
NCT07286214
Primary Objective: To assess, in the same study, the safety of sarilumab a...
Status
Completed
Location
Investigational Site Number 840152
Start Date
2013-03
Trial ID
NCT01768572
Primary Objective: To evaluate the efficacy of sarilumab at Week 16 in par...
Status
Completed
Location
Investigational Site Number 840008
Start Date
2013-10
Trial ID
NCT01900431
Treatments Being Tested
Primary Objectives: Part A (dose ranging study): To demonstrate that sari...
Status
Completed
Location
Investigational Site Number 840070
Start Date
2010-03
Trial ID
NCT01061736
Treatments Being Tested
Primary Objective: To evaluate the efficacy of KEVZARA (sarilumab) in part...
Status
Terminated
Location
Investigational Site Number 8400003
Start Date
2018-10-09
Trial ID
NCT03600818
Primary Objective: To evaluate the efficacy of sarilumab in participants w...
Status
Terminated
Location
Investigational Site Number 8400002
Start Date
2018-11-20
Trial ID
NCT03600805
Treatments Being Tested
Primary Objective: -To demonstrate that sarilumab added to methotrexate (M...
Status
Completed
Location
Investigational Site Number 392010
Start Date
2014-11
Trial ID
NCT02293902
Treatments Being Tested
Primary Objective: To evaluate the clinical efficacy of sarilumab relative...
Status
Completed
Location
Investigational Site Number 0320001
Start Date
2020-03-28
Trial ID
NCT04327388
Treatments Being Tested